01—Abstract
Summary
Summary of the 8-K filed October 13, 2026. Cited figures are marked; the original filing is the authoritative source.
Zoetis Inc. (NYSE: ZTS) filed a Form 8-K on October 13, 2026 disclosing the appointment of Iris Knobloch to its Board of Directors, effective December 1, 2026.
Under Item 5.02, the Board appointed Ms. Knobloch on October 8, 2026, to serve on the Corporate Governance Committee, and the Board size will expand from twelve to thirteen members. The filing states she was not selected under any arrangement with a third party and has no reportable related-party transactions. She will receive the standard non-employee director compensation and enter into the Company's standard indemnification agreement.
The appointment is a governance event rather than a financial one. The filing contains no financial results, guidance, M&A activity, or changes to executive management, and it does not affect Zoetis's reported financials or operations. Investors should view it as routine board refreshment, with the most notable element being the addition of a director with consumer, digital, and international media experience to a company in animal health.
Ms. Knobloch's current board seats at Deezer, Lazard, and Vail Resorts, along with her past roles, could be relevant to how the board addresses consumer strategy and digital initiatives. The Company's CEO, Kristin Peck, and Board Chair, Michael McCallister, both praised the appointment, linking it to the Company's innovation strategy, customer engagement, and new ways to reach pet owners.
The Item 7.01 press release is furnished, not filed, and carries no material new financial information. Overall, the filing is low-impact for near-term valuation and fundamentals.
02—Key points
Key Highlights
- Board appointment: Iris Knobloch appointed to Zoetis's Board of Directors, effective December 1, 2026, with the Board expanding from 12 to 13 members.
- Committee assignment: Ms. Knobloch will serve on the Corporate Governance Committee.
- Independence and related parties: The Company states she was not appointed under any third-party arrangement and has no reportable related-party transactions under Item 404(a).
- Compensation: She will be eligible for the standard non-employee director compensation program described in the 2026 proxy statement filed April 8, 2026.
- Indemnification: She will enter into the Company's standard indemnification agreement, previously filed as Exhibit 10.19 to a 2012 Form S-1 amendment.
- Background: Ms. Knobloch is President of the Festival de Cannes (since July 2022), Chair of Deezer's board, and a director of Lazard, Inc. and Vail Resorts, Inc.
- No financial impact: The filing contains no earnings, guidance, or executive management changes, and the press release is furnished under Item 7.01, not filed.
03—Questions
Frequently Asked Questions
Who is Iris Knobloch and why was she appointed to Zoetis's Board?
Ms. Knobloch is a senior media and consumer executive who has served as President of the Festival de Cannes since July 2022 and as Chair of Deezer's Board since January 2023. She previously held senior roles at WarnerMedia and its predecessors. Zoetis cited her consumer strategy, digital transformation, international leadership, and public company board experience as relevant to its innovation and pet-owner engagement goals.
Does this appointment change Zoetis's financial outlook?
No. The 8-K contains no financial results, guidance, or operational updates. It is a governance disclosure that adds a director and increases the Board size by one seat.
When does the appointment take effect, and what committee will she join?
The appointment is effective December 1, 2026, although the Board made the decision on October 8, 2026. Ms. Knobloch will serve on the Corporate Governance Committee.
Are there any conflicts of interest or related-party concerns?
The Company states that Ms. Knobloch was not appointed under any arrangement with a third party and that there have been no related-party transactions since the start of the last fiscal year that would require disclosure under Item 404(a) of Regulation S-K.
What compensation will the new director receive?
She will be eligible for the Company's non-employee director compensation program, which is described under 'Compensation of Directors' in Zoetis's 2026 proxy statement filed April 8, 2026. The filing does not specify individual compensation amounts.
04—Continue